Longevity News

Disappointing results from the first rapamycin-plus-exercise trial

Source: Peter Attia • Published: 02 May 2026, 11:00

Disappointing results from the first rapamycin-plus-exercise trial

The RAPA-EX-01 randomized double-blind trial assigned weekly 6 mg sirolimus with exercise in 65–85-year-olds and found modestly smaller improvements in 30-second chair-stand performance versus placebo.

Key Takeaways
  • RAPA-EX-01 randomized 40 sedentary adults aged 65–85 to 6 mg weekly sirolimus or placebo for 13
  • Primary outcome was change in 30-second chair-stand repetitions
  • ITT result did not reach conventional significance (p=0.089)
Read Original Source